Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?
Repository Usage Stats
Published Version (Please cite this version)10.1002/pbc.25471
Publication InfoStrouse, John J (2015). Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?. Pediatr Blood Cancer, 62(6). pp. 929-930. 10.1002/pbc.25471. Retrieved from http://hdl.handle.net/10161/13040.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Associate Professor of Medicine
My research has focused on the epidemiology, risk factors, and prevention of the pulmonary and central nervous system complications of sickle cell disease and includes retrospective and prospective cohort studies and clinical trials. I received my Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health for a series of studies to identify predictors of cognitive function in children with sickle cell disease. This work has expanded to the evaluation